Biography:
Fereshteh Sedaghat, M.D. Ph. D from Neuroscience Private Clinic, Mashhad, IRAN and Aristotle University of Thessaloniki, First department of Neurology, Greece.
This is to inform that due to some circumstances beyond the organizer control, “2nd International Conference on Orphan Drugs and Rare Diseases” (ORPHAN DRUGS 2025) scheduled during March 13-15, 2025 in Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at orphan-drugs@magnusconference.com or call + 1 (702) 988 2320.
Fereshteh Sedaghat, M.D. Ph. D from Neuroscience Private Clinic, Mashhad, IRAN and Aristotle University of Thessaloniki, First department of Neurology, Greece.
Title : Covid-19 seems to be Initiated by the heparan-sulfate dysregulation by coronavirus: The use of low-molecular- weight heparin (LMWH) can prevent and treat covid-19 when it Is used in early stages, as a heparan-sulfate-regulating medicine